摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1S)-1,5-anhydro-2,3,4,6-tetra-O-benzyl-1-[2-(benzyloxy)-5-[4-[2-[[[[1-[1-(4-methylpiperazin-1-yl)carbonyl]-1-(methyl)ethyl]amino]carbonyl]amino]ethyl]benzyl]-4-methylphenyl]-D-glucitol | 957774-52-6

中文名称
——
中文别名
——
英文名称
(1S)-1,5-anhydro-2,3,4,6-tetra-O-benzyl-1-[2-(benzyloxy)-5-[4-[2-[[[[1-[1-(4-methylpiperazin-1-yl)carbonyl]-1-(methyl)ethyl]amino]carbonyl]amino]ethyl]benzyl]-4-methylphenyl]-D-glucitol
英文别名
1-[2-methyl-1-(4-methylpiperazin-1-yl)-1-oxopropan-2-yl]-3-[2-[4-[[2-methyl-4-phenylmethoxy-5-[(2S,3S,4R,5R,6R)-3,4,5-tris(phenylmethoxy)-6-(phenylmethoxymethyl)oxan-2-yl]phenyl]methyl]phenyl]ethyl]urea
(1S)-1,5-anhydro-2,3,4,6-tetra-O-benzyl-1-[2-(benzyloxy)-5-[4-[2-[[[[1-[1-(4-methylpiperazin-1-yl)carbonyl]-1-(methyl)ethyl]amino]carbonyl]amino]ethyl]benzyl]-4-methylphenyl]-D-glucitol化学式
CAS
957774-52-6
化学式
C67H76N4O8
mdl
——
分子量
1065.36
InChiKey
DNHALDJPSABNMM-PSIUPGOHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    10.1
  • 重原子数:
    79
  • 可旋转键数:
    24
  • 环数:
    9.0
  • sp3杂化的碳原子比例:
    0.34
  • 拓扑面积:
    120
  • 氢给体数:
    2
  • 氢受体数:
    9

文献信息

  • C-PHENYL GLYCITOL COMPOUND
    申请人:Kakinuma Hiroyuki
    公开号:US20100022460A1
    公开(公告)日:2010-01-28
    Provided is a novel C-phenyl glycitol compound that may serve as a prophylactic or therapeutic agent for diabetes by inhibiting both SGLT1 activity and SGLT2 activity, thereby exhibiting a glucose absorption suppression action and a urine glucose excretion action. A C-phenyl glycitol compound represented by Formula (I) below or a pharmaceutically acceptable salt thereof or a hydrate thereof wherein R 1 and R 2 are the same or different and represent a hydrogen atom, a hydroxyl group, a C 1-6 alkyl group, a C 1-6 alkoxy group or a halogen atom, R 3 is a hydrogen atom, a C 1-6 alkyl group, a C 1-6 alkoxy group or a halogen atom, Y is a C 1-6 alkylene group, —O—(CH 2 )n— (n is an integer of 1 to 4) or a C 2-6 alkenylene group, provided that when Z is —NHC(═NH)NH 2 or —NHCON(R B )R C , n is not 1, Z is —CONHR A , —NHC(═NH)NH 2 or —NHCON(R B )R C ,
    提供的是一种新型C-苯基甘露醇化合物,可以作为预防或治疗糖尿病的药物,通过抑制SGLT1活性和SGLT2活性,从而表现出抑制葡萄糖吸收和尿液葡萄糖排泄的作用。该化合物表示为以下式子(I)的C-苯基甘露醇化合物,或其药学上可接受的盐或合物,其中R1和R2相同或不同,表示氢原子、羟基、C1-6烷基、C1-6烷氧基或卤素原子,R3表示氢原子、C1-6烷基、C1-6烷氧基或卤素原子,Y表示C1-6烷基、-O-(CH2)n-(n为1至4的整数)或C2-6烯基烷基,但当Z为-NHC(=NH)NH2或-NHCON(RB)RC时,n不为1,Z为CONHRA,-NHC(=NH)NH2或-NHCON(RB)RC。
查看更多